HomeCompareEMKT vs JNJ

EMKT vs JNJ: Dividend Comparison 2026

EMKT yields 7.76% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMKT wins by $13.4K in total portfolio value
10 years
EMKT
EMKT
● Live price
7.76%
Share price
$25.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.4K
Annual income
$1,268.09
Full EMKT calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EMKT vs JNJ

📍 EMKT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMKTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMKT + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMKT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMKT
Annual income on $10K today (after 15% tax)
$659.43/yr
After 10yr DRIP, annual income (after tax)
$1,077.88/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, EMKT beats the other by $374.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMKT + JNJ for your $10,000?

EMKT: 50%JNJ: 50%
100% JNJ50/50100% EMKT
Portfolio after 10yr
$26.7K
Annual income
$1,047.94/yr
Blended yield
3.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EMKT
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMKT buys
0
JNJ buys
0
No recent congressional trades found for EMKT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMKTJNJ
Forward yield7.76%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$33.4K$20.0K
Annual income after 10y$1,268.09$827.78
Total dividends collected$10.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EMKT vs JNJ ($10,000, DRIP)

YearEMKT PortfolioEMKT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,476$775.80$10,676$355.77+$800.00EMKT
2$13,111$832.04$11,407$389.39+$1.7KEMKT
3$14,917$888.42$12,198$426.53+$2.7KEMKT
4$16,906$944.69$13,056$467.62+$3.9KEMKT
5$19,090$1,000.60$13,987$513.12+$5.1KEMKT
6$21,483$1,055.94$14,998$563.56+$6.5KEMKT
7$24,097$1,110.53$16,098$619.52+$8.0KEMKT
8$26,948$1,164.18$17,295$681.69+$9.7KEMKT
9$30,051$1,216.75$18,599$750.82+$11.5KEMKT
10$33,423$1,268.09$20,022$827.78+$13.4KEMKT

EMKT vs JNJ: Complete Analysis 2026

EMKTStock

EMKT focuses on equity securities of companies whose principal business activities are in emerging market countries, as defined by the MSCI Emerging Markets universe. The fund invests mainly in common stocks, but may also hold preferred and convertible securities, including depositary receipts. The strategy emphasizes identifying companies that appear undervalued relative to their earnings, cash flows, or asset values. While the fund can invest across market capitalizations, implementation may from time to time lead to greater exposure to larger companies depending on market conditions. The portfolio may also experience periods of higher weighting in particular sectors or regions as a result of bottom-up stock selection rather than top-down allocation. Under normal conditions, at least 80% of net assets are invested in securities tied to emerging markets. EMKT converted from the Lazard Emerging Markets Core Equity portfolio with $ 123.8 million in assets.

Full EMKT Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EMKT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMKT vs SCHDEMKT vs JEPIEMKT vs OEMKT vs KOEMKT vs MAINEMKT vs ABBVEMKT vs MRKEMKT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.